Insulin Aspart Protamine Injection and Mogamulizumab-kpkc
Determining the interaction of Insulin Aspart Protamine Injection and Mogamulizumab-kpkc and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Aspart Protamine Injection-Mogamulizumab-kpkc Intravenous
- Insulin Aspart Protamine Injection-Molindone
- Insulin Aspart Protamine Injection-Mometasone (Oral Inhalation)
- Insulin Aspart Protamine Injection-Mometasone and Formoterol
- Insulin Aspart Protamine Injection-Mometasone and formoterol Inhalation
- Insulin Aspart Protamine Injection-Mometasone Cream
- Mogamulizumab-kpkc-Insulin aspart, recombinant Subcutaneous
- Mogamulizumab-kpkc-Insulin degludec
- Mogamulizumab-kpkc-Insulin Degludec (U-100) Prefilled Pens
- Mogamulizumab-kpkc-Insulin Degludec (U-100) Vials
- Mogamulizumab-kpkc-Insulin Degludec (U-200) Prefilled Pens
- Mogamulizumab-kpkc-Insulin degludec and liraglutide